Facebook
Linkedin
Pinterest
Reddit
Twitter
Medical Devices
Biotechnology
Clinical Trials
Mergers & Acquisitions
Funding
FDA
Industry Expert Articles
Other News
Market Reports
Executives
Hospitals
Imaging
Ultrasound
Health
Articles
Search
Sunday, January 12, 2025
LinkedIn
Twitter
Facebook
Instagram
Pinterest
Trending Now
Vergent Bioscience Receives FDA Fast Track Designation for Abenacianine for Injection (VGT-309) to Help Surgeons Visualize Tumors in the Lung During Surgery
Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
PharmaEssentia Reaffirms its Commitment to Robust and Reliable Access to Interferon Therapies Amid Global Supply Challenges
50% of Older Adults to Rely on Wearables for Life-Saving Alerts by 2034, ScienceSoft Predicts
YolTech Therapeutics Granted FDA Orphan Drug and Rare Pediatric Disease Designations for YOLT-203 to Treat Primary Hyperoxaluria Type 1
Search
Home
About
Press Releases
Editorial
Advertise
Contact
Privacy Statement
Medical Device News Magazine
A Digital Publication for the Practicing Medical Specialist & Industry Investor
Florida / New York
Medical Devices
Biotechnology
Clinical Trials
Mergers & Acquisitions
Funding
FDA
Industry Expert Articles
Other News
Market Reports
Executives
Hospitals
Imaging
Ultrasound
Health
Articles
Home
Progentec Diagnostics Announces Launch of Novel Test That Anticipates Onset of Lupus-Related Flares
Progentec Lupus Test
Progentec Lupus Test
September 15, 2020
Progentec Lupus Test
